| Source: |
| Type: |
| Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors. |
| 28- | GEN, | Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway |
| - | in-vivo, | BC, | MCF7 |
| 6566- | Ger, | 5-FU, | Geraniol, a Component of Plant Essential Oils, Sensitizes Human Colonic Cancer Cells to 5-Fluorouracil Treatment |
| - | in-vitro, | CRC, | NA |
| 6562- | Ger, | Potential Effects of Geraniol on Cancer and Inflammation-Related Diseases: A Review of the Recent Research Findings |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6564- | Ger, | Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2 |
| - | in-vitro, | HCC, | HepG2 |
| 6567- | Ger, | Geraniin inhibits proliferation and induces apoptosis through inhibition of phosphatidylinositol 3-kinase/Akt pathway in human colorectal cancer in vitro and in vivo |
| - | vitro+vivo, | CRC, | SW480 | - | in-vitro, | CRC, | HT29 |
| 6570- | Ger, | Apoptosis-Mediated Anticancer Activity of Geraniol Inhibits NF-κB, MAPK, and JAK-STAT-3 Signaling Pathways in Human Thyroid Cancer Cells |
| - | in-vitro, | Thyroid, | TPC-1 |
| 7274- | GGB, | The potential immunotherapy effect of Ginkgolide B thwarts oral squamous cell carcinoma progression by targeting the SREBP1/KLK8/CCL22 axis |
| - | vitro+vivo, | Oral, | KYSE-510 | - | in-vitro, | Oral, | TE1 |
| 7287- | GGB, | Rad, | Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway |
| - | in-vitro, | Lung, | NA |
| 7288- | GGB, | Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments |
| - | in-vitro, | BC, | MDA-MB-231 |
| 7136- | GI, | [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2 |
| - | vitro+vivo, | NSCLC, | H1650 |
| 7139- | GI, | 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | GBM, | U251 |
| 7138- | GI, | 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 |
| 1005- | GI, | Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells |
| - | vitro+vivo, | Nor, | HUVECs |
| 7242- | Gink, | Cisplatin, | Ginkgetin reverses cisplatin resistance in cervical cancer by regulating the Nrf2/HO-1 signaling pathway to induce ferroptosis |
| - | in-vitro, | Cerv, | HeLa |
| 7247- | Gink, | Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT474 | - | vitro+vivo, | BC, | MCF7 |
| 7249- | Gink, | RES, | Synergy of Ginkgetin and Resveratrol in Suppressing VEGF-Induced Angiogenesis: A Therapy in Treating Colorectal Cancer |
| - | vitro+vivo, | CRC, | NA |
| 7251- | Gink, | Ginkgetin: A Promising Multitarget Agent for Diverse Diseases |
| - | Review, | Var, | NA |
| 7266- | Gink, | Ginkgo biloba derivative ginkgetin inhibits breast cancer growth by regulating the miRNA-122-5p/GALNT10 axis |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-453 | - | in-vitro, | BC, | MCF7 |
| 7265- | Gink, | Ginkgetin targets GRP78 to induce dual pathways of ER stress and immune activation in osteosarcoma |
| - | vitro+vivo, | OS, | NA |
| 7262- | Gink, | Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | SKOV3 |
| 7284- | Gins, | 5-FU, | Ginsenoside Rg3 enhances the anticancer effect of 5-FU in colon cancer cells via the PI3K/AKT pathway |
| - | vitro+vivo, | CRC, | SW-620 | - | in-vitro, | CRC, | LoVo |
| 4513- | GLA, | Antineoplastic Effects of Gamma Linolenic Acid on Hepatocellular Carcinoma Cell Lines |
| - | in-vitro, | Liver, | HUH7 |
| 4505- | GLA, | Gamma linolenic acid suppresses hypoxia-induced proliferation and invasion of non-small cell lung cancer cells by inhibition of HIF1α |
| - | in-vitro, | NSCLC, | Calu-1 |
| 855- | Gra, | Antiproliferative activity of ionic liquid-graviola fruit extract against human breast cancer (MCF-7) cell lines using flow cytometry techniques |
| - | in-vitro, | BC, | MCF7 |
| 854- | Gra, | AgNPs, | Green Synthesis of Silver Nanoparticles Using Annona muricata Extract as an Inducer of Apoptosis in Cancer Cells and Inhibitor for NLRP3 Inflammasome via Enhanced Autophagy |
| - | vitro+vivo, | AML, | THP1 | - | in-vitro, | AML, | AMJ13 | - | vitro+vivo, | lymphoma, | HBL |
| 7327- | GSE, | Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats |
| - | in-vivo, | CRC, | NA |
| 7324- | GSE, | A Pilot Study of a Grape Seed Procyanidin Extract for Lung Cancer Chemoprevention |
| - | Trial, | Lung, | NA |
| 30- | GSL, | A sesquiterpene lactone from Siegesbeckia glabrescens suppresses Hedgehog/Gli-mediated transcription in pancreatic cancer cells |
| - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | AsPC-1 |
| 108- | GSL, | A sesquiterpene lactone from Siegesbeckia glabrescens suppresses Hedgehog/Gli-mediated transcription in pancreatic cancer cells |
| - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | AsPC-1 | - | in-vitro, | PC, | C3H10T1/2 |
| 7482- | H2, | Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application |
| - | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA | - | Review, | Sepsis, | NA | - | Review, | AD, | NA |
| 7489- | H2, | Molecular Hydrogen in the Treatment of Respiratory Diseases |
| - | Review, | Asthma, | NA |
| 2523- | H2, | Prospects of molecular hydrogen in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2519- | H2, | Hydrogen: an advanced and safest gas option for cancer treatment |
| - | Review, | Var, | NA |
| 2517- | H2, | Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response |
| - | in-vitro, | Var, | A549 | - | in-vitro, | NA, | HCT116 | - | in-vitro, | NA, | HeLa | - | in-vitro, | NA, | HepG2 | - | in-vitro, | NA, | HT1080 | - | in-vitro, | NA, | PC3 | - | in-vitro, | NA, | SH-SY5Y |
| 7502- | H2S, | Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 | - | in-vitro, | CRC, | LoVo |
| 7504- | H2S, | New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors |
| - | Review, | PC, | NA |
| 7523- | HCA, | Inhibition of ATP Citrate Lyase by Hydroxycitrate-Loaded Exosomes Suppresses the Survival of Lung Adenocarcinoma Cells |
| - | in-vitro, | Lung, | NA |
| 1643- | HCAs, | Mechanisms involved in the anticancer effects of sinapic acid |
| - | Review, | Var, | NA |
| 7169- | HDN-1, | CHA, | Identification of epipolythiodioxopiperazines HDN-1 and chaetocin as novel inhibitor of heat shock protein 90 |
| - | in-vitro, | Lung, | H1975 | - | in-vitro, | Lung, | HCC827 | - | in-vitro, | Lung, | A549 |
| 7359- | HibSad, | Novel Insight into the Cellular and Molecular Signalling Pathways on Cancer Preventing Effects of Hibiscus sabdariffa: A Review - PubMed |
| - | Review, | Var, | NA |
| 7348- | Hne, | Apoptosis‐inducing activity of Helleborus nigerin ALL and AML |
| - | in-vitro, | AML, | NA |
| 7345- | Hne, | A root extract of Helleborus niger possess cytotoxic properties in neuroblastoma cells |
| - | in-vitro, | neuroblastoma, | NXS2 |
| 7341- | Hne, | Preclinical evaluation of safety and potential of black hellebore extracts for cancer treatment |
| - | Review, | Var, | NA |
| 7340- | Hne, | Differential cytotoxic properties of Helleborus niger L. on tumour and immunocompetent cells |
| - | in-vitro, | AML, | NA |
| 7339- | Hne, | Apoptosis-inducing activity of Helleborus niger in ALL and AML |
| - | in-vitro, | AML, | NA |
| 7458- | HNK, | Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2 |
| - | in-vitro, | Ovarian, | OVCAR-3 |
| 7466- | HNK, | PDT, | MET, | Enhanced integrated therapy for breast cancer employing Honokiol-loaded mesoporous polydopamine nanoparticles in conjunction with photothermal effects and low-dose metformin |
| - | in-vitro, | BC, | NA |
| 7467- | HNK, | Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation |
| - | vitro+vivo, | Oral, | NA |
| 7456- | HNK, | Honokiol in the treatment of triple-negative breast cancer: a network pharmacology approach and experimental validation |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
| 7459- | HNK, | Honokiol Exhibits Anti-Tumor Effects in Breast Cancer by Modulating the miR-148a-5p-CYP1B1 Axis |
| - | in-vitro, | BC, | MDA-MB-231 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:327 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid